Medicare Enrolled

Dr. Allison Moore, MSN

Physician Assistant · Dallas, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
3410 WORTH ST, Dallas, TX 75246
2148208500
In practice since 2006 (19 years)
NPI: 1770643843 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Moore from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Moore? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Moore

Dr. Allison Moore is a physician assistant in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. Moore performed 763 Medicare services across 278 unique beneficiaries.

Between the years covered by Open Payments, Dr. Moore received a total of $5,438 from 18 pharmaceutical and/or device companies across 270 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Moore is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 17% volume in TX$ $5,438 industry payments

Medicare Practice Summary

Medicare Utilization ↗
763
Medicare services
Top 17% in TX for physician assistant
278
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~40 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Infusion, albumin (human), 25%, 50 ml300$41$180
Blood draw (venipuncture)129$8$17
Office visit, established patient (30-39 min)99$76$238
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less80$43$244
Office visit, established patient (20-29 min)56$53$168
Drainage of fluid from abdominal cavity using imaging guidance49$185$1,010
Office visit, established patient, complex (40-54 min)36$111$335
Ultrasound scan of organ tissue for measuring elasticity14$61$373
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
49.8% high complexity
8.3% medium
41.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,438
Total received (2021-2024)
Avg $1,360/year across 4 years
Top 5% in TX for physician assistant
18
Companies
270
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,438 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,124
2023
$1,421
2022
$1,237
2021
$1,657

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Gilead Sciences, Inc.
$1,911
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,136
ABBVIE INC.
$719
AbbVie Inc.
$597
INTERCEPT PHARMACEUTICALS, INC.
$334
Ipsen Biopharmaceuticals, Inc
$118
Mallinckrodt Hospital Products Inc.
$118
Intercept Pharmaceuticals, Inc.
$102
Dova Pharmaceuticals
$70
Alexion Pharmaceuticals, Inc.
$68
Madrigal Pharmaceuticals
$68
Novartis Pharmaceuticals Corporation
$48
Sobi, Inc
$39
VBI Vaccines (Delaware) Inc.
$31
Novo Nordisk Inc
$22
VBI Vaccine (Delaware) Inc.
$20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$19
Dynavax Technologies Corporation
$19
Top 3 companies account for 69.2% of total payments
Associated products mentioned in payments ›
Bylvay · CAPLYTA · CREON · DOPTELET · Doptelet · Heplisav-B · IQIRVO · MAVYRET · OCALIVA · Ozempic · PreHevbrio · RESMETIROM · SYNAGIS · TERLIVAZ · ULTOMIRIS · VIEKIRA PAK · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for physician assistant in TX.

Equivalent to $713 per 100 Medicare services performed
Looking for a physician assistant in Dallas?
Compare physician assistants in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician Assistants within 10 mi
736
Per 100K population
28.3
County median income
$74,149
Nearest hospital
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Moore is a clinical cardiology specialist, with above-average Medicare volume (top 17% in TX), and high industry engagement (low-engagement, top 5%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Moore experienced with infusion, albumin (human), 25%, 50 ml?
Based on Medicare claims data, Dr. Moore performed 300 infusion, albumin (human), 25%, 50 ml services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Moore receive payments from pharmaceutical companies?
Yes. Dr. Moore received a total of $5,438 from 18 companies across 270 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Moore's costs compare to other physician assistants in Dallas?
Dr. Moore's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Moore) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →